Primary Job Title Founder Primary Organization 
Lysosomal Therapeutics
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Ted Sybertz, Ph.D., held various research leadership positions at Schering Plough, Geltex and Genzyme, focusing on cardiovascular and CNS diseases. At Genzyme, he played a leadership role in discovery and preclinical development of the glucosyl ceramide synthesis inhibitor, eliglustat. He has been associated with the discovery and introduction of
over 20 molecules into clinical development, six of which were ultimately approved.
